Truist Securities Maintains Buy on Ardent Health, Raises Price Target to $13

Ardent Health, Inc.

Ardent Health, Inc.

ARDT

0.00

Truist Securities analyst David Macdonald maintains Ardent Health (NYSE: ARDT) with a Buy and raises the price target from $12 to $13.